Login

Chorus CCO Ed Hyde and Enable CEO Johnathan Eele discuss the latest industry research on AM on Three. 00:10:00

Share On Facebook Share On Twitter

JB has been the CEO of Chorus since 2019.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Thinkific Labs Inc., a publicly traded company on the TSX , owns the trademark Thinkific.
00:10:00
Interview with Doug Gruer, CEO of Emu NL on Assay TV
00:10:00
Adapting Portfolio Strategy and Economic Outlook: Insights from a Real Estate CEO | Roger Waesche Jr., CEO, Corporate Office Properties Trust.
00:10:00
Accelerating Drug Development Through Superior Innovative Solutions|Ronnie Morris, MD,Champions Oncology Inc
00:10:00
Cenergy Holdings: €0.08 dividend per share with a €3 billion backlog | Alexios Alexiou, CEO, Cenergy Holdings SACENER:BRU
00:10:00
Unpacking Absolute Return Strategies: Neil Capecci on Global Fixed Income and Client-Centered Investing | Neil Capecci - Portfolio Manager, Manulife
00:10:00
JSA Insights – 2nd Quarter of 2022 | Jacobson & Schmitt Advisors
00:10:00
In The Studio: How EPC and Wolfspeed are Changing the Way We Live | David Costar, CIO, Wolfspeed IncWOLF:NYQ
00:10:00
Dr. Daniel Matjila, CEO of the Public Investment Corporation, receives awards for Asset Management Firm of the Year and Best Corporate.
00:00:00
Tom Ulich, CSO, InVivo Therapeutics Holdings Corp
00:10:00
Alliance Resources: Rapidly Advancing Gold Projects in Western Australia
00:10:00
Revolutionizing Healthcare Staffing: Harnessing Technology for Efficiency and Success | Cary Grace - President & Chief Executive Officer of AMN HEALTHCARE SERVICES INC

© 2017 - Neuhu+